Status
Conditions
About
In this study, we aim to assess whether Patient Derived Organoids can be used to predict treatment sensitivity in HNSCC patients.
Full description
This is a prospective observation study to generate patient-derived organoids from patients' samples to assess treatment response and to correlate with patients' treatment outcomes and to collect preliminary data on the ability of PDOs to predict patients' treatment response and whether their radiosensitivity and chemosensitivity can be correlated with their survival outcome.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
60 participants in 3 patient groups
Loading...
Central trial contact
Anthony Kong; Ifigenia Vasiliadou
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal